Loading viewer...
investor_presentation
Format: PDF investor_presentation
Non-operating franchise focused on commodity infrastructure across three core U.S. basins. Company generated $450MM in free cash flow in 2022 with accelerating growth in 2023, maintaining a disciplined capital allocation strategy and strong balance sheet targeting <1.0x Net Debt to Adjusted EBITDA.
investor_presentation
18 Pages
investor_presentation
34 Pages
SBI Life Insurance
Tonix Tonmya TNX-102 SL Fibromyalgia 2024
investor_presentationinvestor_presentation
22 Pages
Tonix Pharmaceuticals Holding Corp.